HL-686: Role of Targeted Immune Therapies in Relapsed/Refractory Hodgkin Lymphoma—A Multicenter, Lower-Middle-Income Country Experience From Various Transplant Centers in Pakistan
Year: 2026
Type: conference-abstract
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Keywords: relapsed/refractory Hodgkin lymphoma, brentuximab vedotin, nivolumab, autologous stem cell transplantation, treatment response, treatment toxicity, overall survival, progression-free survival, G-CSF mobilization, plerixafor, lower-middle-income countries, Pakistan, real-world outcomes, PET response assessment, engraftment
Open Access status: closed
OpenAlex ID: W7204695243
